MA38171B1 - Évaluation du risque d’insuffisance rénale aiguë suite a une chirurgie cardiaque - Google Patents

Évaluation du risque d’insuffisance rénale aiguë suite a une chirurgie cardiaque

Info

Publication number
MA38171B1
MA38171B1 MA38171A MA38171A MA38171B1 MA 38171 B1 MA38171 B1 MA 38171B1 MA 38171 A MA38171 A MA 38171A MA 38171 A MA38171 A MA 38171A MA 38171 B1 MA38171 B1 MA 38171B1
Authority
MA
Morocco
Prior art keywords
renal failure
acute renal
cardiac surgery
risk assessment
following cardiac
Prior art date
Application number
MA38171A
Other languages
English (en)
Other versions
MA38171A1 (fr
Inventor
Frank Dieterle
Holger Hoefling
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA38171A1 publication Critical patent/MA38171A1/fr
Publication of MA38171B1 publication Critical patent/MA38171B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

La présente invention concerne un procédé de prédiction de la gravité d'une insuffisance rénale aiguë suite à une chirurgie cardiaque.
MA38171A 2012-12-20 2013-12-18 Évaluation du risque d’insuffisance rénale aiguë suite a une chirurgie cardiaque MA38171B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261740303P 2012-12-20 2012-12-20
PCT/EP2013/077253 WO2014096110A1 (fr) 2012-12-20 2013-12-18 Insuffisance rénale aiguë

Publications (2)

Publication Number Publication Date
MA38171A1 MA38171A1 (fr) 2016-11-30
MA38171B1 true MA38171B1 (fr) 2017-07-31

Family

ID=49885245

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38171A MA38171B1 (fr) 2012-12-20 2013-12-18 Évaluation du risque d’insuffisance rénale aiguë suite a une chirurgie cardiaque

Country Status (20)

Country Link
US (1) US20150309052A1 (fr)
EP (1) EP2936160A1 (fr)
JP (2) JP6416778B2 (fr)
KR (1) KR20150096728A (fr)
CN (1) CN104871004A (fr)
AR (1) AR094118A1 (fr)
AU (2) AU2013360685A1 (fr)
BR (1) BR112015014232A2 (fr)
CA (1) CA2895096A1 (fr)
CL (1) CL2015001768A1 (fr)
HK (1) HK1209838A1 (fr)
IL (1) IL239431A0 (fr)
MA (1) MA38171B1 (fr)
MX (1) MX2015008108A (fr)
PH (1) PH12015501399A1 (fr)
RU (1) RU2015129496A (fr)
SG (1) SG11201504329RA (fr)
TN (1) TN2015000263A1 (fr)
TW (1) TW201430347A (fr)
WO (1) WO2014096110A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019037043A1 (fr) * 2017-08-24 2019-02-28 菲鹏生物股份有限公司 Kit de détection d'une lésion rénale aiguë
CN108986915B (zh) * 2018-07-24 2021-07-06 戴松世 人工智能的急性肾损伤的早期预测方法和装置
WO2020064995A1 (fr) * 2018-09-28 2020-04-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Utilisation de biomarqueurs représentant des voies cardiaques, vasculaires et inflammatoires permettant la prédiction d'une lésion rénale aiguë chez des patients atteints de diabète de type 2
KR20200042725A (ko) 2018-10-16 2020-04-24 (주) 솔 렌즈 프리 cmos 광자 어레이 센서의 노이즈 특성 평가 방법
WO2020251833A1 (fr) * 2019-06-11 2020-12-17 The Regents Of The University Of California Systèmes et méthodes d'identification fondée sur un apprentissage automatique d'une lésion rénale aiguë en chirurgie traumatologique et chez des patients brûlés
CN110441457A (zh) * 2019-08-02 2019-11-12 深圳市绿航星际太空科技研究院 一种检测尿液中同型半胱氨酸的方法
CN112114125A (zh) * 2020-08-27 2020-12-22 中国医学科学院北京协和医院 一种评估肾脏储备功能的方法和系统及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002033417A1 (fr) * 2000-10-17 2002-04-25 Besst-Test Aps Dosage servant a la detection directe d'une cellule biologique associee au virus rs, dans un echantillon de fluide organique
JP2004511808A (ja) * 2000-10-17 2004-04-15 ベッスト−テスト　アンパーツゼルスカブ 体液サンプル中の生物学的細胞の直接的検出のためのアッセイ
AU2001295442A1 (en) * 2000-10-17 2002-04-29 Besst-Test Aps Assay for directly detecting an inflammatory indicator in a body fluid sample
US20090238812A1 (en) * 2008-03-18 2009-09-24 Biotrin Intellectual Properties Limited Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery
CN102264230B (zh) * 2008-11-10 2014-12-10 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
US20110287964A1 (en) * 2008-11-17 2011-11-24 The Brigham And Women's Hospital, Inc. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans
KR101939964B1 (ko) * 2008-11-21 2019-01-18 퓨처 메디칼 다이아그노스틱스 코 엘티디 급성 신장 손상의 발견 또는 감시 방법, 장치 및 키트
CN101706497A (zh) * 2009-11-05 2010-05-12 武汉三鹰生物技术有限公司 人tff3的elisa检测试剂盒
EP2496942B1 (fr) * 2009-11-07 2017-03-22 Astute Medical, Inc. Méthodes et compositions de diagnostic et de pronostic de lésion rénale et d'insuffisance rénale
CA2798713A1 (fr) * 2010-05-10 2011-11-17 Intrinsic Lifesciences Llc Marqueurs de lesion renale aigue
WO2012094657A1 (fr) * 2011-01-08 2012-07-12 Astute Medical, Inc. Procédé et compositions pour diagnostiquer et pronostiquer une lésion rénale et une insuffisance rénale

Also Published As

Publication number Publication date
US20150309052A1 (en) 2015-10-29
PH12015501399A1 (en) 2015-09-07
JP2016503162A (ja) 2016-02-01
TN2015000263A1 (fr) 2016-10-03
JP6416778B2 (ja) 2018-10-31
CN104871004A (zh) 2015-08-26
TW201430347A (zh) 2014-08-01
JP2019053067A (ja) 2019-04-04
HK1209838A1 (en) 2016-04-08
EP2936160A1 (fr) 2015-10-28
CA2895096A1 (fr) 2014-06-26
CL2015001768A1 (es) 2015-10-09
RU2015129496A (ru) 2017-01-26
AU2013360685A1 (en) 2015-07-02
MA38171A1 (fr) 2016-11-30
WO2014096110A1 (fr) 2014-06-26
IL239431A0 (en) 2015-07-30
KR20150096728A (ko) 2015-08-25
SG11201504329RA (en) 2015-07-30
BR112015014232A2 (pt) 2017-07-11
MX2015008108A (es) 2015-11-06
AU2017232081A1 (en) 2017-10-12
AR094118A1 (es) 2015-07-08

Similar Documents

Publication Publication Date Title
MA38171B1 (fr) Évaluation du risque d’insuffisance rénale aiguë suite a une chirurgie cardiaque
CY1123172T1 (el) Δοκιμασια για συλληψη και ανιχνευση κυκλοφορουντων κυτταρων πολλαπλου μυελωματος απο αιμα
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
CY1121981T1 (el) Μεθοδος για τον προσδιορισμο κινδυνου pml
EP2705475A4 (fr) Systèmes de gestion de médicaments à l'échelle d'une installation
BR112014001004A2 (pt) método para determinar a condição operacional futura de um objeto
EP2862033A4 (fr) Procédé et système de détermination de l'utilisation de la durée de vie d'une pièce mécanique
EP2737851A4 (fr) Lancette de sécurité ayant une fonction de prévention de réutilisation à sécurité intégrée
EA201200239A1 (ru) Бициклические арильные аналоги сфингозин 1-фосфата
EP2958982A4 (fr) Procédés de récupération d'huile à partir de micro-organismes
EP2715041A4 (fr) Ensemble de jonction de forages multiples à haute pression
EP2771127A4 (fr) Source de fluide à pulvérisateur comportant une doublure rétractable
EA201590024A1 (ru) Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток
BR112015028253A2 (pt) biomarcadores relacionados à função renal e métodos para utilização dos mesmos
EP2831557A4 (fr) Système de détection de l'emplacement d'une fuite
EP3060687A4 (fr) Procédé d'ébavurage d'une pièce formée à chaud
BR112012016767A2 (pt) Método para diagnosticar se um paciente sofre de uma condição hepática ou do fígado, método para detectar o desenvolvimento de uma patologia do fígado, método para deter5 minar o risco de um paciente para uma condição do fígado e sistema para diagnosticar o estado de saúde hepática
WO2013023144A3 (fr) Profils de biomarqueur de diagnostic pour détection et diagnostic de la maladie de parkinson
EP2861331A4 (fr) Procédé non dispersif pour la récupération d'huile insoluble à partir de sources liquides
FR2979686B1 (fr) Peigne multifonctionnel de fixation de tuyauterie metallique et procede de fixation d'une telle tuyauterie
EP2881403A4 (fr) Protéine contenant un agent désactivateur formée à partir d'un multimère de type tandem d'un domaine extracellulaire muté de la protéine g
EP2898722A4 (fr) Procédé de prise en charge de l'indication d'un événement d'échec à un système d'accès source
FR2992426B1 (fr) Procede de determination de la contrainte a la rupture par cisaillement d'une piece d'epaisseur determinee
EP2749015A4 (fr) Procédé de gestion automatisée de contacts sortants requérant une connexion assurée à un agent vivant
EP2914580A4 (fr) Dérivés de thioaryle à titre d'agonistes de gpr120